Atrion Corporation operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Atrion with three other
companies in this sector in the United States:
sales of $156.47 million
of which 100%
was License Fee),
SeaSpine Holdings Corp
of which 53%
was Orthobiologics), and
Tactile Systems Technology Inc
of which 92%
was Flexitouch system).
Atrion reported sales of $152.45 million
December of 2018.
increase of 4.0%
versus 2017, when the company's sales were $146.60 million.
Sales of Fluid Delivery saw an increase
that was more than double the company's growth rate: sales were up
8.5% in 2018, from
$65.05 million to $70.61 million.
Atrion also saw significant increases in sales in
Cardiovascular (up 5.9% to $50.90 million)
Not all segments of Atrion experienced an increase in sales in 2018:
sales of Opthalmology fell 22.6% to $10.47 million.